Literature DB >> 22713157

Pseudotyped adeno-associated viral vector tropism and transduction efficiencies in murine wound healing.

Sundeep G Keswani1, Swathi Balaji, Louis Le, Alice Leung, Foong-Yen Lim, Mounira Habli, Helen N Jones, James M Wilson, Timothy M Crombleholme.   

Abstract

Cell specific gene transfer and sustained transgene expression are goals of cutaneous gene therapy for tissue repair and regeneration. Adeno-associated virus serotype 2 (AAV2/2) mediated gene transfer to the skin results in stable transgene expression in the muscle fascicles of the panniculus carnosus in mice, with minimal gene transfer to the dermal or epidermal elements. We hypothesized that pseudotyped AAV vectors may have a unique and characteristic tropism and transduction efficiency profile for specific cells in the cutaneous wounds. We compared transduction efficiencies of cells in the epidermis, cells in the dermis, and the fascicles of the panniculus carnosus by AAV2/2 and three pseudotyped AAV vectors, AAV2/5, AAV2/7, and AAV2/8 in a murine excisional wound model. AAV2/5 and AAV2/8 result in significantly enhanced transduction of cells both in the epidermis and the dermis compared to AAV2/2. AAV2/5 transduces both the basilar and supra-basilar keratinocytes. In contrast, AAV2/8 transduces mainly supra-basilar keratinocytes. Both AAV2/7 and AAV2/8 result in more efficient gene transfer to the muscular panniculus carnosus compared to AAV2/2. The capsid of the different pseudotyped AAV vectors produces distinct tropism and efficiency profiles in the murine wound healing model. Both AAV2/5 and AAV2/8 administration result in significantly enhanced gene transfer. To further characterize cell specific transduction and tropism profiles of the AAV pseudotyped vectors, we performed in vitro experiments using human and mouse primary dermal fibroblasts. Our data demonstrate that pseudotyping strategy confers a differential transduction of dermal fibroblasts, with higher transduction of both human and murine cells by AAV2/5 and AAV2/8 at early and later time points. At later time points, AAV2/2 demonstrates increased transduction. Interestingly, AAV2/8 appears to be more efficacious in transducing human cells as compared to AAV2/5. The pseudotype-specific pattern of transduction and tropism observed both in vivo and in vitro suggests that choice of AAV vectors should be based on the desired target cell and the timing of transgene expression in wound healing for gene transfer therapy in dermal wounds.
© 2012 by the Wound Healing Society.

Entities:  

Mesh:

Year:  2012        PMID: 22713157      PMCID: PMC3654388          DOI: 10.1111/j.1524-475X.2012.00810.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  29 in total

1.  Defining the epithelial stem cell niche in skin.

Authors:  Tudorita Tumbar; Geraldine Guasch; Valentina Greco; Cedric Blanpain; William E Lowry; Michael Rendl; Elaine Fuchs
Journal:  Science       Date:  2003-12-11       Impact factor: 47.728

Review 2.  Recombinant adeno-associated virus as delivery vector for gene therapy--a review.

Authors:  Yang Lu
Journal:  Stem Cells Dev       Date:  2004-02       Impact factor: 3.272

3.  Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene.

Authors:  Luis G Melo; Reitu Agrawal; Lunan Zhang; Mojgan Rezvani; Abeel A Mangi; Afshin Ehsan; Daniel P Griese; Giorgio Dell'Acqua; Michael J Mann; Junichi Oyama; Shaw-Fang Yet; Matthew D Layne; Mark A Perrella; Victor J Dzau
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

4.  Selective uptake and sustained expression of AAV vectors following subcutaneous delivery.

Authors:  B A Donahue; J G McArthur; S K Spratt; D Bohl; C Lagarde; L Sanchez; B A Kaspar; B A Sloan; Y L Lee; O Danos; R O Snyder
Journal:  J Gene Med       Date:  1999 Jan-Feb       Impact factor: 4.565

5.  Adeno-associated virus expresses transgenes in hair follicles and epidermis.

Authors:  U R Hengge; A Mirmohammadsadegh
Journal:  Mol Ther       Date:  2000-09       Impact factor: 11.454

6.  Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

Authors:  A Girod; M Ried; C Wobus; H Lahm; K Leike; J Kleinschmidt; G Deléage; M Hallek
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

7.  Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb.

Authors:  David S Chang; Hua Su; Gale L Tang; Lucy S Brevetti; Rajabrata Sarkar; Rong Wang; Yuet W Kan; Louis M Messina
Journal:  Mol Ther       Date:  2003-01       Impact factor: 11.454

8.  A comparison of targeting performance of oncoretroviral versus lentiviral vectors on human keratinocytes.

Authors:  Fernando Serrano; Marcela Del Rio; Fernando Larcher; Marta Garcia; Evangelina Muñoz; María José Escamez; Marta Muñoz; Alvaro Meana; Antonio Bernad; José Luis Jorcano
Journal:  Hum Gene Ther       Date:  2003-11-01       Impact factor: 5.695

9.  Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses.

Authors:  Lorraine M Work; Hildegard Büning; Ela Hunt; Stuart A Nicklin; Laura Denby; Nicola Britton; Kristen Leike; Margarete Odenthal; Uta Drebber; Michael Hallek; Andrew H Baker
Journal:  Mol Ther       Date:  2006-01-04       Impact factor: 11.454

10.  Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors.

Authors:  Mariacarmela Allocca; Claudio Mussolino; Maria Garcia-Hoyos; Daniela Sanges; Carolina Iodice; Marco Petrillo; Luk H Vandenberghe; James M Wilson; Valeria Marigo; Enrico M Surace; Alberto Auricchio
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

View more
  9 in total

1.  Multiple recombinant adeno-associated viral vector serotypes display persistent in vivo gene expression in vector-transduced rat stifle joints.

Authors:  Jeffrey B Mason; Brittney L Gurda; Julie B Engiles; Kurt D Hankenson; James M Wilson; Dean W Richardson
Journal:  Hum Gene Ther Methods       Date:  2013-06       Impact factor: 2.396

2.  Cross-Presentation of Skin-Targeted Recombinant Adeno-associated Virus 2/1 Transgene Induces Potent Resident Memory CD8+ T Cell Responses.

Authors:  David-Alexandre Gross; Alexandre Ghenassia; Laurent Bartolo; Dominique Urbain; Sofia Benkhelifa-Ziyyat; Stéphanie Lorain; Jean Davoust; Pascal Chappert
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

3.  Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy.

Authors:  Jessica Sallach; Giovanni Di Pasquale; Fernando Larcher; Nadine Niehoff; Matthias Rübsam; Anke Huber; Jay Chiorini; David Almarza; Sabine A Eming; Hikmet Ulus; Stephen Nishimura; Ulrich T Hacker; Michael Hallek; Carien M Niessen; Hildegard Büning
Journal:  Mol Ther       Date:  2014-01-28       Impact factor: 11.454

4.  Robust Lentiviral Gene Delivery But Limited Transduction Capacity of Commonly Used Adeno-Associated Viral Serotypes in Xenotransplanted Human Skin.

Authors:  Maria Jakobsen; Anne Louise Askou; Karin Stenderup; Cecilia Rosada; Frederik Dagnæs-Hansen; Thomas G Jensen; Thomas J Corydon; Jacob Giehm Mikkelsen; Lars Aagaard
Journal:  Hum Gene Ther Methods       Date:  2015-08       Impact factor: 2.396

5.  Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts: implications for wound-healing applications.

Authors:  Swathi Balaji; Alice King; Yashu Dhamija; Louis D Le; Aimen F Shaaban; Timothy M Crombleholme; Sundeep G Keswani
Journal:  J Surg Res       Date:  2013-04-03       Impact factor: 2.192

6.  Pseudotyped AAV vector-mediated gene transfer in a human fetal trachea xenograft model: implications for in utero gene therapy for cystic fibrosis.

Authors:  Sundeep G Keswani; Swathi Balaji; Louis Le; Alice Leung; Anna B Katz; Foong-Yen Lim; Mounira Habli; Helen N Jones; James M Wilson; Timothy M Crombleholme
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

Review 7.  Progresses towards safe and efficient gene therapy vectors.

Authors:  Sergiu Chira; Carlo S Jackson; Iulian Oprea; Ferhat Ozturk; Michael S Pepper; Iulia Diaconu; Cornelia Braicu; Lajos-Zsolt Raduly; George A Calin; Ioana Berindan-Neagoe
Journal:  Oncotarget       Date:  2015-10-13

8.  Allele-specific silencing of EEC p63 mutant R304W restores p63 transcriptional activity.

Authors:  F Novelli; A M Lena; E Panatta; W Nasser; R Shalom-Feuerstein; E Candi; G Melino
Journal:  Cell Death Dis       Date:  2016-05-19       Impact factor: 8.469

9.  Knockdown of the KINDLIN-2 Gene and Reduced Expression of Kindlin-2 Affects Vascular Permeability in Angiogenesis in a Mouse Model of Wound Healing.

Authors:  Jianghui Ying; Wenjie Luan; Lu Lu; Simin Zhang; Fazhi Qi
Journal:  Med Sci Monit       Date:  2018-08-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.